The Independent Uganda: You get the Truth we Pay the Price
The non-intrusive machine can treat several cancerous and non-cancerous tumours, saving many patients the costs of travelling abroad to seek its services
Nairobi, Kenya | BIRD AGENCY | In 2018, Edith Karaini’s husband visited the hospital for what he thought was a minor consultation.
“He had been complaining of sharp abdominal pain for about four months, so he went to the hospital to find out its cause and seek treatment. The last thing on our mind was a prostate cancer diagnosis,” said Karaini.
Her husband died two years after being diagnosed, after the family failed to raise the 10 million shillings (US$79,000) needed for specialised treatment in India.
Karaini says by the time of her husband’s death, she had spent Ksh 15 million (USD$118,000) on his treatment locally.
More than the pain of his passing, the consequences of it made it even harder.
“We never saw it coming. It hit us hard. We were ruined psychologically, economically, and socially. Cancer treatment turned us into beggars,” said the widow.
Like Karaini, many cancer patients in Kenya are struggling not only with accessing specialised treatment but also raising millions of shillings needed for such treatment abroad.
India and South Africa have become the most preferred destinations for Kenyans seeking cancer treatment.
Cancer statistics in Kenya
According to the National Cancer Institute of Kenya (NCI), cancer is the third leading cause of death in Kenya and the second leading cause of non-communicable diseases after cardiovascular diseases.
Data from NCI shows that the risk of developing cancer in Kenya before the age of 75 years is 18% among women and 14.3% among men, while the risk of dying from cancer by the same age is 12.7% in women compared with 10.3% in men.
The five common cancers in Kenya are breast, cervical, prostate, oesophageal, and colorectal.
NCI cites the high cost of cancer diagnosis and treatment and limited service availability as key challenges facing cancer management and control in Kenya.
Accompanied the CEO @kutrrh to inspect the ongoing installation of the CyberKnife. The engineers assured us the installation is on schedule for commissioning soon. Project has taken a little longer than expected due to complexity & safety of the bunker. Glad it's now on course. pic.twitter.com/7kzbWFzNSW
— Prof. Olive Mugenda Ph.D., CBS, MGH (@OliveMugenda) February 22, 2023
Huge Relief
But now, cancer patients in Kenya might have a reprieve after a leading referral hospital acquired a state-of-the-art modern cancer treatment technology that seeks to cut the cost of treating the disease.
The Kenyatta University Teaching Research and Referral Hospital (KUTRRH) has installed CyberKnife’s stereotactic radiosurgery (SRS), and stereotactic body radiation therapy (SBRT) system, which enables clinicians to deliver precise, highly effective radiation treatment.
“Our focus is to ensure speedy delivery of treatment, efficiency and patient comfort,” said the hospital’s CEO, Dr Ahmed Dagane.
The USD$5.3 million investment enables doctors to better provide a diagnosis and treat tumours without damaging tissue.
“It will not only cut down cancer treatment costs, but we will also provide relief to families who have had to wait for ages to access treatment,” Dagane noted.
KUTRRH management Board Chair Professor Olive Mugenda said the new technology would drastically cut the costs of accessing cancer treatment for Kenyans.
“With Cyberknife the cost of cancer treatment has been brought down to 350,000 shillings down from the current 2 million shillings charged for similar treatment,” said Mugenda.
“Kenyans need not travel abroad anymore,” she added.
KUTRRH has set a daily target of treating ten patients to manage the huge number of patients seeking the service.
******
SOURCE: By Jackson Okata | bird story agency
